Our Opinion

Progenity Inc. is on the Cruelty Free Investing list for exploiting animals because the company does animal testing for some of its medical analysis and clinical research.

Supporting Evidence:

The company stated in the following news article that they use animals for product testing.

“The study consisted of administration of a fully functional DDS device containing a mixture of acetaminophen and sulfasalazine in a canine animal model.” Read the following article

Company Description

Progenity, Inc., a biotechnology company, provides develops and commercializes molecular testing products in the United States. The company develops targeted oral delivery of biotherapeutics, including PGN-600, an orally delivered liquid formulation of tofacitinib for the treatment of ulcerative colitis; and PGN-001, an orally delivered variant of adalimumab for the treatment of ulcerative colitis. The company was founded in 2010 and is headquartered in San Diego, California.

Company Website: https://www.progenity.com